BioNeutra Global Corporation
BGACF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -15% | -13.1% | -36.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 36.4% | 17.5% | 18.8% | 16.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3.1% | -10.2% | -7.2% | -6.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -18.5% | -21.8% | -18.4% | -15.4% |
| EPS Diluted | -0.045 | -0.063 | -0.061 | -0.08 |
| % Growth | 27.8% | -3.3% | 23.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |